More people die of Alzheimer’s disease than prostate and breast cancer combined. Identifying the disease before major symptoms arise is critical to preserving brain function and helping patients maintain quality of life. A new study presented at the 2017 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) demonstrates that a single dual time-point PET scan could identify important biomarkers of Alzheimer’s disease.
from Dementia Big http://ift.tt/2s9vfMI via alcoholic dementia
http://ift.tt/2t2JyCI
No comments:
Post a Comment